Total Payments
$5,223
2024 Payments
$2,194
Companies
23
Transactions
202
Medicare Patients
2,550
Medicare Billing
$437,008
Payment Breakdown by Category
Food & Beverage$5,215 (99.8%)
Education$8.90 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,215 | 201 | 99.8% |
| Education | $8.90 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $800.30 | 34 | $0 (2024) |
| ABBVIE INC. | $737.11 | 18 | $0 (2024) |
| Novo Nordisk Inc | $563.87 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $549.87 | 14 | $0 (2024) |
| Allergan, Inc. | $461.95 | 16 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $335.88 | 24 | $0 (2024) |
| PFIZER INC. | $277.19 | 13 | $0 (2022) |
| GENZYME CORPORATION | $249.95 | 13 | $0 (2024) |
| Amgen Inc. | $232.86 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $177.15 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,194 | 87 | Lilly USA, LLC ($479.26) |
| 2023 | $1,358 | 59 | Novo Nordisk Inc ($324.62) |
| 2022 | $569.03 | 16 | ABBVIE INC. ($437.33) |
| 2021 | $176.17 | 4 | Insmed, Inc. ($109.97) |
| 2020 | $46.49 | 2 | Allergan, Inc. ($46.49) |
| 2019 | $106.75 | 5 | PFIZER INC. ($86.72) |
| 2018 | $450.25 | 16 | Allergan Inc. ($280.49) |
| 2017 | $322.78 | 13 | Allergan Inc. ($134.97) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: Immunology | ||||||
| 11/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $44.11 | General |
| Category: NONE | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardio-renal | ||||||
| 09/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Obesity | ||||||
| 09/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: Inflammation | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: Immunology | ||||||
| 08/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: Inflammation | ||||||
| 08/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Respiratory | ||||||
| 08/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $18.97 | General |
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $118.75 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 621 | 1,498 | $242,013 | $117,099 |
| 2022 | 11 | 692 | 1,720 | $263,903 | $131,637 |
| 2021 | 9 | 608 | 1,185 | $214,173 | $91,825 |
| 2020 | 10 | 629 | 1,102 | $215,872 | $96,447 |
Total Patients
2,550
Total Services
5,505
Medicare Billing
$437,008
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 119 | 373 | $63,931 | $33,865 | 53.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 462 | $55,509 | $28,789 | 51.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 151 | $33,152 | $14,985 | 45.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 140 | 167 | $29,799 | $14,338 | 48.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 81 | 94 | $22,175 | $9,191 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 62 | $7,556 | $4,285 | 56.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 22 | $9,758 | $3,670 | 37.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 22 | $6,965 | $2,616 | 37.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $3,518 | $1,795 | 51.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 17 | 18 | $1,885 | $1,468 | 77.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,102 | $1,232 | 30.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 28 | 28 | $733.04 | $570.36 | 77.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 28 | $1,485 | $294.87 | 19.9% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2023 | 11 | 46 | $1,445 | $0.80 | 0.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 156 | 561 | $90,259 | $45,818 | 50.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 124 | 690 | $77,259 | $39,811 | 51.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 156 | 186 | $30,735 | $15,903 | 51.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 72 | 81 | $25,228 | $12,383 | 49.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 42 | 47 | $9,989 | $5,128 | 51.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 20 | 26 | $11,532 | $4,260 | 36.9% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 41 | 41 | $8,535 | $3,795 | 44.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 38 | 38 | $4,275 | $1,981 | 46.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 19 | 19 | $2,148 | $1,100 | 51.2% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 12 | 13 | $2,063 | $798.39 | 38.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2022 | 12 | 18 | $1,879 | $659.86 | 35.1% |
About Dr. Ky Le, MD
Dr. Ky Le, MD is a Internal Medicine healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073560025.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ky Le, MD has received a total of $5,223 in payments from pharmaceutical and medical device companies, with $2,194 received in 2024. These payments were reported across 202 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,215).
As a Medicare-enrolled provider, Le has provided services to 2,550 Medicare beneficiaries, totaling 5,505 services with total Medicare billing of $437,008. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Aiea, HI
- Active Since 05/27/2006
- Last Updated 10/19/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073560025
Products in Payments
- DUPIXENT (Biological) $427.10
- MOUNJARO (Drug) $396.50
- UBRELVY (Drug) $376.45
- AVYCAZ (Drug) $339.58
- Kerendia (Drug) $335.88
- FASENRA (Biological) $312.93
- DALVANCE (Drug) $238.71
- ELIQUIS (Drug) $225.64
- TEZSPIRE (Biological) $198.44
- JARDIANCE (Drug) $136.04
- CHANTIX (Drug) $133.52
- WAKIX (Drug) $125.00
- Repatha (Biological) $118.75
- BOTOX (Biological) $114.57
- Ozempic (Drug) $112.76
- Rybelsus (Drug) $111.50
- Arikayce (Drug) $109.97
- ZEPBOUND (Drug) $103.40
- Reveal LINQ (Device) $99.83
- Otezla (Drug) $97.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aiea
Roy Ebisu, Md, MD
Internal Medicine — Payments: $18,765
Internal Medicine $18,765
Stephen Miyasato, Md, MD
Internal Medicine — Payments: $18,084
Internal Medicine $18,084
Dr. Francis Buto, M.d, M.D
Internal Medicine — Payments: $14,868
Internal Medicine $14,868
Dr. Alan Oki, Md, MD
Internal Medicine — Payments: $14,573
Internal Medicine $14,573
Mark Nishihara, M.d, M.D
Internal Medicine — Payments: $14,206
Internal Medicine $14,206
Dr. Malissa Iida-Takashima, Md, MD
Internal Medicine — Payments: $13,761
Internal Medicine $13,761